Parallax Volatility Advisers’s Editas Medicine EDIT Stock Holding History

Parallax Volatility Advisers’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,000	Closed	-$117K	–	2247
2023 Q3	$117K	Hold	15,000	–	–	﹤0.01%	1901
2023 Q2	$123K	Hold	15,000	–	–	﹤0.01%	1972
2023 Q1	$109K	Hold	15,000	–	–	﹤0.01%	2114
2022 Q4	$133K	Sell	15,000 -102,500	-87%	-$1.13M	﹤0.01%	2223
2022 Q3	$1.44M	Hold	117,500	–	–	﹤0.01%	1578
2022 Q2	$1.39M	Buy	117,500 +15,000	+15%	+$201K	﹤0.01%	1511
2022 Q1	$1.95M	Sell	102,500 -100,600	-50%	-$1.87M	﹤0.01%	1372
2021 Q4	$5.39M	Sell	203,100 -100	-0%	-$3.44K	﹤0.01%	1158
2021 Q3	$8.35M	Sell	203,200 -31,100	-13%	-$1.7M	0.01%	1022
2021 Q2	$13.3M	Buy	234,300 +186,600	+391%	+$6.89M	0.01%	784
2021 Q1	$2M	Buy	+47,700	New	+$2.72M	﹤0.01%	1748

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parallax Volatility Advisers's EDIT Position: Q4 2023 in Review

Parallax Volatility Advisers sold out of Editas Medicine (EDIT) in Q4 2023, closing a stake of 1,845 shares — an estimated $14.4K sold.

Parallax Volatility Advisers first reported a position in EDIT in Q4 2017 and held it in 13 quarters. The position peaked at $2.89M in Q4 2021. 226 funds tracked by Wall St. Rank hold EDIT as of Q4 2023.

Parallax Volatility Advisers reported no remaining Editas Medicine position as of Q4 2023 after selling out during the quarter.
Parallax Volatility Advisers sold 1,845 Editas Medicine shares in Q4 2023, an estimated $14.4K.
Parallax Volatility Advisers first reported a position in Editas Medicine in Q4 2017 and held it in 13 quarters.
Parallax Volatility Advisers's Editas Medicine position peaked at $2.89M in Q4 2021.
226 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2023.

Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.